Decentralised trials don’t remove responsibility. They move it.

As more clinical trial activity happens outside the traditional research site, we’re asking patients, local healthcare providers, technology vendors and connected devices to become part of the trial ecosystem.

That creates opportunity. But it also creates complexity.

If a patient is completing an ePRO remotely, using eCOA, connecting to a wearable or participating hundreds of miles from the research site, the technology underneath that interaction has to work. Every time.

The conversation therefore can’t just be about the application. It has to include the infrastructure carrying the data.

That infrastructure layer has to deliver on:

• Device consistency
• Connectivity
• Security
• Remote management
• Software and firmware control
• Long-term device availability
• Global deployment and support

At STK Life, this is exactly how we think about clinical trial technology. With STK Helix, our goal isn’t simply to provide another smartphone. It’s to provide a controlled, purpose-built infrastructure layer that helps eCOA, ePRO and other digital trial technologies operate consistently wherever the patient happens to be.

Because moving the trial closer to the patient only works if the infrastructure can move with it.